[ACRX] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
08-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- -19.35%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 5,416 2,289 2,151 7,995 17,357 19,263 5,217 0.62%
PBT -40,375 -53,237 -47,147 -52,209 -43,191 -23,639 -33,353 3.23%
Tax 4 3 2 -701 -34 760 6,935 -71.11%
NP -40,379 -53,240 -47,149 -51,508 -43,157 -24,399 -33,353 3.23%
Tax Rate - - - - - - - -
Total Cost 45,795 55,529 49,300 59,503 60,514 43,662 38,570 2.90%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -745.55 -2,325.91 -2,191.96 -644.25 -248.64 -126.66 -639.31 2.59%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -9.47 -13.45 -16.14 -21.97 -19.05 -11.02 -15.36 -7.73%
EPS Diluted -9.47 -13.45 -16.14 -21.97 -19.05 -10.97 -15.05 -7.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.